---

Background and Aim: Diabetes is a chronic disease that physiological, cognitive, behavioral, emotional and social factors play a role in preventing, risk and regulating it. This research aimed to predict blood glucose control by the use of irrational health beliefs and health locus of control in patients with type 2 diabetes. Materials and Methods: The research population consisted of all type 2 diabetic patients referring to the two centers of Alzahra School of Charity Hospital and Diabetes Research Institute of Tehran University of Medical Sciences that 300 patients were chosen as sample by convenience sampling method. Data were gathered by using Multidimensional Health Locus of Control Scale (MHLC) and Irrational Health Belief Scale (IHBS) and analyzed by regression. Ethical Considerations: This study was approved in Research Ethics Committee of biomedical researches in Tehran Universiry with the code IR.ut.Rec.1395.030. Findings: There is a significant correlation between the predictive variables of irrational health beliefs (p <0.05), inner locus of control and others (p <0.05), and chance locus of control (p <0.01). The results also indicate that the health locus of control and Irrational beliefs predict significantly the changes in the amount of glucose (R=19, R2=0.037, F(4. 293)=2.80, p<0.05). Conclusion: Based on the findings of this study, we can say that by identifying the health locus of control and irrational health beliefs, it is possible that blood glucose level can be predicted in patients with type 2 diabetes and reduced the consequences of diabetes in people with it.

---

Background and Aim Oxidative stress is the main factor in the development and progression of diabetes and its related complications. There is growing evidence that antioxidants supplementation can improve oxidative stress induced in diabetes. The present investigation was conducted to study the effects of Coenzyme Q10 (CoQ10) on the Oxidative Stress Index (OSI) in diabetic rats.
Methods and Materials A total of 30 male rats were divided into five groups: saline, sesame oil (as a vehicle), CoQ10-treated (10 mg/kg/day), diabetic (induced with streptozotocin: 55 mg/kg), and CoQ10-treated diabetic (10 mg/kg/d). Then, we measured the Malondialdehyde (MDA), Total Oxidant Status (TOS), and Total Antioxidant Capacity (TAC) levels in the rats’ liver homogenate. Additionally, the OSI was calculated.
Ethical Considerations The Research Ethics Committee of Arak University of Medical Sciences approved this study (Code: IR.ARAKMU.REC.1397.119).
Results results showed a significant decrease in the level of liver MDA (P=0.022), TOS (P=0.03), and OSI (P=0.028) in the CoQ10-treated diabetic group compared to the diabetic rats. No significant change was observed in the total thiol group (P=0.25) and TAC (P=0.77) level in diabetic rats’ livers treated with CoQ10 compared to diabetic rats. 

---

Introduction: Diabetic foot ulcer is the most common cause of hospitalization in diabetic people, while one of the prominent sources of anxiety in patients is the time of discharge from the hospital. This study aimed to determine the effect of the SMART discharge protocol on the anxiety of diabetic foot ulcer patients.
Methods: In this semi-experimental study, 50 patients with diabetic foot ulcers Were divided equally into two control (25 patients) and intervention (25 patients) groups, randomly and based on the Inclusion criteria. In the intervention group, the SMART discharge protocol was implemented from their admission to the day of discharge. The Demographic information questionnaire and Spielberger questionnaire were used to determine patients' anxiety. The data were analyzed at two descriptive and inferential levels.
Results: There was no statistically significant difference in the mean score of anxiety for diabetic foot ulcer patients in the two groups before the intervention. In contrast, after the intervention, the mean anxiety score in the two groups showed a statistically significant difference (P = 0.0001).
Conclusions: According to the results of the present study, it seems that the smart discharge protocol was effective in reducing the anxiety of diabetic foot ulcer patients. Therefore, it is recommended that nursing officials and managers implement this protocol.

---

Introduction: Novel antidiabetic medications are employed to manage glycemic control and mitigate the long-term complications of type 2 diabetes. This study aimed to investigate the prevalence of adverse events, including hypoglycemia, associated with these novel antidiabetic agents in a cohort of patients with type 2 diabetes.
Methods: This cross-sectional analytical study was conducted on 157 patients with type 2 diabetes mellitus attending the Endocrinology Clinic at Imam Khomeini Hospital, Urmia, during the summer of 2024. A convenience sampling method was employed to recruit participants. Data on demographics, the incidence of hypoglycemia, and reported adverse drug reactions were collected from all eligible patients through a structured interview. Subsequently, patients were stratified into three treatment groups based on the specific novel antidiabetic medication they received.
Results: In patients receiving sitagliptin, the most prevalent adverse events included arthralgia and rheumatic problems (26.31%), dermatological manifestations (36.84%), and allergic reactions (21.06%). Nausea (52.94%) and abdominal pain (17.65%) were the most frequent adverse events observed in patients treated with liraglutide. Polydipsia (28.72%), weakness and lethargy (26.6%), and dry mucous membranes (27.66%) were commonly reported in patients receiving empagliflozin. Hypoglycemia was observed predominantly in male patients aged 51-55 years receiving sitagliptin.
Conclusions: The findings of this study demonstrate a low incidence of hypoglycemia among patients treated with modern antidiabetic medications. Prevalent short-term adverse events observed included gastrointestinal disturbances, allergic reactions, and dermatological manifestations.